1. Home
  2. PTHL vs NCSM Comparison

PTHL vs NCSM Comparison

Compare PTHL & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • NCSM
  • Stock Information
  • Founded
  • PTHL 1998
  • NCSM 2006
  • Country
  • PTHL China
  • NCSM United States
  • Employees
  • PTHL N/A
  • NCSM N/A
  • Industry
  • PTHL
  • NCSM Oilfield Services/Equipment
  • Sector
  • PTHL
  • NCSM Energy
  • Exchange
  • PTHL Nasdaq
  • NCSM Nasdaq
  • Market Cap
  • PTHL 85.4M
  • NCSM 79.3M
  • IPO Year
  • PTHL 2024
  • NCSM 2017
  • Fundamental
  • Price
  • PTHL $13.50
  • NCSM $30.60
  • Analyst Decision
  • PTHL
  • NCSM
  • Analyst Count
  • PTHL 0
  • NCSM 0
  • Target Price
  • PTHL N/A
  • NCSM N/A
  • AVG Volume (30 Days)
  • PTHL 870.9K
  • NCSM 6.6K
  • Earning Date
  • PTHL 02-11-2025
  • NCSM 07-30-2025
  • Dividend Yield
  • PTHL N/A
  • NCSM N/A
  • EPS Growth
  • PTHL N/A
  • NCSM N/A
  • EPS
  • PTHL N/A
  • NCSM 3.27
  • Revenue
  • PTHL $448,196.00
  • NCSM $168,704,000.00
  • Revenue This Year
  • PTHL N/A
  • NCSM $7.17
  • Revenue Next Year
  • PTHL N/A
  • NCSM $5.44
  • P/E Ratio
  • PTHL N/A
  • NCSM $9.26
  • Revenue Growth
  • PTHL N/A
  • NCSM 18.16
  • 52 Week Low
  • PTHL $1.32
  • NCSM $15.90
  • 52 Week High
  • PTHL $19.05
  • NCSM $38.95
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • NCSM 49.79
  • Support Level
  • PTHL N/A
  • NCSM $28.64
  • Resistance Level
  • PTHL N/A
  • NCSM $30.60
  • Average True Range (ATR)
  • PTHL 0.00
  • NCSM 1.12
  • MACD
  • PTHL 0.00
  • NCSM -0.15
  • Stochastic Oscillator
  • PTHL 0.00
  • NCSM 42.52

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

Share on Social Networks: